anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Authority Citation

Framework collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 2,176
Current window 1,111-1,140
Pages 73
Rows per page 30
Framework: Authority Citationclear collectionreset all
18 30 60

Framework

1,111-1,140 of 2,176

filter-aware
52
The slide uses historical news headlines to illustrate the regulatory and safety failure of the drug Seldane.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
53
The slide uses a historical precedent (Seldane/terfenadine recall) to frame the severity of a current drug's (pitolisant) safety profile, highlighting specific death and exposure statistics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
57
The slide uses a specific research paper abstract to validate the claim of inherent cardiotoxicity.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
91
The slide uses a Q&A transcript format to validate the thesis that the H3 receptor class is fundamentally flawed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
95
The slide uses expert testimony to establish a precedent of failure in the H3 receptor space, specifically contrasting J&J's robust trials with Bioprojet's pitolisant.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
121
The slide presents a direct quote from a PK expert to undermine the validity of the company's safety assertions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
141
The slide uses direct citations from peer-reviewed papers to validate the consultant's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
219
The slide uses a 'villain' framing for the Epworth Sleepiness Scale to justify why it should not be used in the context of the research.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
254
The slide uses direct quotes from a KOL to undermine the market potential of Wakix.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
17
The slide uses a quote from a Quanta Magazine article to support the activist thesis that the target company's technology is fundamentally broken.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology1 hit
30
The slide uses authority-citation to undermine the company's credibility.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Struggle to Overcome Technical Challenges1 hit
73
The slide uses direct quotes highlighted in yellow to support the argument that current technology is lab-bound.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
103
Uses expert testimony to undermine the company's technical claims regarding fidelity.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
104
The slide uses expert testimony to undermine the company's technical claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
110
The slide uses a screenshot of an IEEE Spectrum article to provide external authority for the critique.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Loop · Iceberg1 hit
128
The slide uses a direct expert quote to undermine the company's technical viability.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
12
The slide uses external media citations to establish the company's credibility and historical performance.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularitiesLoop · Aha Moment1 hit
88
The slide contrasts KLA and Lam Research's audit reports with the explicit fraud case of MagnaChip.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
104
The slide contrasts LDP (Laser-assisted Discharge Plasma) used by Lasertec with LPP (Laser Produced Plasma) used by ASML, citing a specific academic paper to validate the critique of LDP's contamination issues.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
107
The slide uses a bilingual (Japanese/English) format to present technical evidence regarding tin debris damage mechanisms.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
280
The slide presents qualitative evidence in a Q&A format to support a thesis about KLA's competitive positioning against Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
284
The slide argues that the CHIPS Act forces companies receiving subsidies to source equipment from US-based suppliers, creating a competitive disadvantage for non-US firms like Lasertec.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
76
Uses testimonials to undermine the company's core value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
92
Uses highlighted quotes to emphasize negative feedback from medical professionals.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
120
Uses testimonials to frame the company as a 'one-tick pony' with a shrinking user base.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
121
Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
135
Uses authority-citation framework to undermine the company's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
141
The slide uses direct quotes from former employees to undermine the company's product strategy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
142
Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
163
Uses multiple pull-quotes from KOLs to build a case against the company's clinical trial integrity.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit